Innovent Biopharmaceutical Transformation
Internally Focus on 7 Major Research Taskforces to Deliver
Global Potential Drugs
With the goal to discover, develop and commercialize potential global blockbuster drugs by 2030, we have 80 research
programs at pre-clinical stage supported by state-of-the-art protein and antibody engineering technologies.
Innovent
Academy Projects
(80 projects & 7
taskforce)
Proprietary
technology
platforms
Monoclonal
antibody
ADC
traditional
ADC ISAC
Multi-
specific
T/NK
engager
Immuno-
cytokine
Polymeric
Pro-drug
IgG
ADC platform, Bispecific platform, Phage and yeast display platform, Hybridoma platform.......
Global discovery
powerhouse
US lab established in 2021
Innovent
Confidential
Copyright©2022 Innovent
Shanghai R&D center in operations by 2023
20
20View entire presentation